StarFill Regulatory Status: Understanding Market Access for Professionals

StarFill is a line of hyaluronic acid dermal fillers developed and manufactured by JETEMA, a South Korean pharmaceutical company. These products are designed for professional aesthetic applications, typically presented in sterile, pre-filled syringes. Clinics and distributors globally source such products for their comprehensive portfolios.

As a South Korean-originated product, primary certification often involves the Korean Ministry of Food and Drug Safety (KFDA). KFDA approval indicates compliance with local manufacturing, safety, and quality standards within South Korea. Additionally, global market access frequently depends on international certifications such as CE marking for the European Economic Area (EEA).

Other critical quality benchmarks include Good Manufacturing Practices (GMP) and ISO certifications, such as ISO 13485 for medical devices. These attest to the robustness of the manufacturer's quality management systems. Specific FDA (US) approval for StarFill for import and sale in the United States typically requires separate applications and review processes. [VERIFY: Specific KFDA approval details for StarFill] and [VERIFY: Specific CE marking status for StarFill].

The CE Mark is a critical requirement for legal distribution and sale of medical devices, including dermal fillers, within the European Union. Products bearing the CE Mark signify conformity with the EU's health, safety, and environmental protection standards. For the United Kingdom, while CE marking has been recognized during a transitional period post-Brexit, UKCA marking requirements are progressively being implemented. Professionals sourcing in these regions must verify the current regulatory status and confirm supplier documentation for compliant stock, similar to how they would approach sourcing Elasty Plus 1CC.

Markets within the Gulf Cooperation Council (GCC), such as the UAE and Saudi Arabia, typically necessitate specific product registration through their national health authorities (e.g., MOHAP in UAE, SFDA in KSA). These processes often involve local agent sponsorship and the submission of original KFDA or CE Mark documentation.

Latin American (LATAM) markets, including Brazil (ANVISA) and Mexico (COFEPRIS), also maintain independent regulatory bodies with distinct approval procedures. These can involve extensive documentation and local clinical data requirements, underscoring the complexity of international market access.

Given its South Korean origin, StarFill generally has established regulatory pathways within many APAC countries. Health authorities such as Singapore's Health Sciences Authority (HSA), Australia's Therapeutic Goods Administration (TGA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA) oversee product registrations. Local regulations for import and distribution are paramount for market entry and sustained availability within this diverse region. For comprehensive information on similar products, professionals can consult resources like the Metoo Fill+ Regulatory Status Guide.

The practice of parallel importing can introduce complexities regarding traceability and product authenticity for aesthetic injectables. While sometimes legal, parallel imports may bypass official distribution channels, potentially complicating warranty claims or product recalls. Professionals should always prioritize sourcing through authorized or verifiable legitimate distributors to ensure product integrity and compliance. A thorough Dermalax Deep Plus Wholesale Sourcing Guide underscores these points.

When sourcing StarFill, clinics and distributors must exercise rigorous due diligence by demanding comprehensive documentation from their suppliers. This includes Certificates of Analysis, verifiable lot numbers, and evidence of cold chain adherence during transit. Crucially, suppliers should provide clear proof of all relevant regulatory approvals (e.g., KFDA, CE Mark, specific national registrations) applicable to the intended market. This commitment to documentation safeguards the clinic's reputation and ensures the quality of products stocked.